Australian Securitization News: Issue 514, Week Ended July 6, 2012 Aug 12

  • ID: 2200651
  • August 2012
  • Region: Australia
  • Standard & Poors
1 of 2

The Australian Securitization News is a weekly periodical that provides insight into the Australian securitization market. It provides statistics on market activity, number of transactions, volume of transactions, and RMBS performance, including SPIN and SPPI charts. Australian/New Zealand ABS Performance Watch, RMBS Performance Watch, and Inside ABCP publications can be found in the Global Research Publications window within RatingsDirect Global Credit Portal. Select 'Structured Finance Research' from the drop-down menu within this window, which is located on the right-hand navigation pane. The Australian SPIN, Australian RMBS Arrears Statistics, Australian SPPI, and some of the articles listed in Table 4 are also available on www.standardandpoors.com.au. Click on Structured Finance and search for them under the RMBS tab....

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.